We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6473:TSEJTEKT Corporation Analysis

Data as of 2026-03-15 - not real-time

NT$7.82

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 7.82 TWD, just above the calculated support of 7.47 TWD and below the 20‑day SMA of 8.10, indicating limited upside. Technicals show a bullish trend direction but the MACD line sits below its signal, producing a bearish signal, and volume is on a decreasing trend, suggesting weakening momentum. RSI at 48 points to a neutral position, while the 30‑day volatility of over 350% and a max drawdown of –56% highlight extreme price swings. The beta of 0.34 points to low market‑wide sensitivity, yet the stock’s thin trading volume raises liquidity concerns.
Fundamentally the company is in distress: revenue has plunged 60% year‑over‑year, gross margin remains high at 66% but operating and profit margins are deeply negative, and both operating and free cash flow are large negatives. The balance sheet shows more cash (79.8 M TWD) than debt (43.7 M TWD), but the debt‑to‑equity ratio of 22.8% and a negative ROE of –32% underscore earnings weakness. No dividend is paid, and analysts have not issued any coverage, leaving the valuation largely driven by the price‑to‑book of 1.63. Given the combination of deteriorating fundamentals, high volatility, and limited upside, the stock appears undervalued from a pure price‑to‑book perspective but carries substantial downside risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD histogram
  • Decreasing volume trend
  • Negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support
  • Low beta reducing market risk
  • Potential upside if cash is deployed to restructure

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Continued revenue decline
  • Sustained negative profitability
  • High volatility and drawdown risk

Key Metrics & Analysis

Financial Health

Revenue Growth-59.70%
Profit Margin-50.18%
ROE-32.59%
ROA-14.21%
Debt/Equity22.79
P/B Ratio1.6
Op. Cash FlowNT$-97094000
Free Cash FlowNT$-68612624
Industry P/E17.8

Technical Analysis

TrendBullish
RSI48.6
SupportNT$7.47
ResistanceNT$9.57
MA 20NT$8.10
MA 50NT$7.77
MA 200NT$7.06
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.34
Volatility350.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.